UNIQURE NV (QURE) Forecast, Price Target & Analyst Ratings

NASDAQ:QURENL0010696654

Current stock price

16.27 USD
+1.09 (+7.18%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for UNIQURE NV (QURE).

Forecast Snapshot

Consensus Price Target

Price Target
$51.51
+ 216.59% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.89
Revenue Estimate
5.327M

ChartMill Buy Consensus

Rating
80.91%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$51.51
Upside
+ 216.59%
From current price of $16.27 to mean target of $51.51, Based on 22 analyst forecasts
Low
$27.27
Median
$49.98
High
$99.75

Price Target Revisions

1 Month
0.00%
3 Months
-9.67%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for QURE. The average price target is 51.51 USD. This implies a price increase of 216.59% is expected in the next year compared to the current price of 16.27.
The average price target has been revised downward by 9.67% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

QURE Current Analyst RatingQURE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

QURE Historical Analyst RatingsQURE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
80.91%
QURE was analyzed by 22 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about QURE.
In the previous month the buy percentage consensus was at a similar level.
QURE was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-23BarclaysMaintains Equal-Weight -> Equal-Weight
2026-03-11MizuhoUpgrade Neutral -> Outperform
2026-03-10HC Wainwright & Co.Reiterate Buy -> Buy
2026-03-09Chardan CapitalMaintains Buy -> Buy
2026-03-09RBC CapitalUpgrade Sector Perform -> Outperform
2026-03-09Wells FargoUpgrade Equal-Weight -> Overweight
2026-03-03Chardan CapitalMaintains Buy -> Buy
2026-03-03MizuhoDowngrade Outperform -> Neutral
2026-03-03Wells FargoDowngrade Overweight -> Equal-Weight
2026-03-03Goldman SachsMaintains Neutral -> Neutral
2026-03-02Cantor FitzgeraldUpgrade Overweight -> Neutral
2026-02-24Wolfe ResearchInitiate Peer Perform
2026-02-10HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-28BarclaysInitiate Equal-Weight
2025-12-11StifelMaintains Buy -> Buy
2025-12-09MizuhoMaintains Outperform -> Outperform
2025-12-04Chardan CapitalMaintains Buy -> Buy
2025-11-12Wells FargoMaintains Overweight -> Overweight
2025-11-11Chardan CapitalMaintains Buy -> Buy
2025-11-10Leerink PartnersMaintains Outperform -> Outperform
2025-11-04William BlairDowngrade Outperform -> Market Perform
2025-11-04RBC CapitalMaintains Outperform -> Outperform
2025-11-04Goldman SachsMaintains Neutral -> Neutral
2025-11-04HC Wainwright & Co.Maintains Buy -> Buy
2025-11-03Chardan CapitalMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.89
Revenue Estimate
5.327M
Revenue Q2Q
239.95%
EPS Q2Q
-8.49%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-5.48%
Revenue (3 Months)
-5.48%
EPS (1 Month)
6.60%
EPS (3 Months)
6.32%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 5.48% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
QURE revenue by date.QURE revenue by date.
15.843M
-85.12%
27.119M
71.17%
16.098M
-40.64%
36.401M
126.12%
113.04M
210.54%
143.22M
26.70%
509.53M
255.77%
858.69M
68.53%
1.073B
24.96%
814.9M
-24.05%
862.1M
5.79%
EBITDA
YoY % growth
QURE ebitda by date.QURE ebitda by date.
-270.971M
-101.17%
-164.463M
39.31%
-170.29M
-3.54%
-153.075M
10.11%
-123.385M
19.40%
-132.232M
-7.17%
171.68M
229.83%
542.73M
216.13%
655.08M
20.70%
767.64M
17.18%
N/A
EBIT
YoY % growth
QURE ebit by date.QURE ebit by date.
-282.871M
-97.54%
-177.104M
37.39%
-185.049M
-4.49%
-202.81M
-9.60%
-166.005M
18.15%
-250.673M
-51.00%
125.3M
149.99%
401.3M
220.27%
669.84M
66.92%
562.4M
-16.04%
202M
-64.08%
Operating Margin
QURE operating margin by date.QURE operating margin by date.
-1,785.46%-653.06%-1,149.52%-557.16%-146.86%-175.03%24.59%46.73%62.43%69.01%23.43%
EPS
YoY % growth
QURE eps by date.QURE eps by date.
-6.48
-138.72%
-4.95
23.62%
-3.53
28.69%
-3.46
2.09%
-2.18
36.93%
0.68
131.06%
2.20
224.63%
6.02
173.83%
9.47
57.38%
6.88
-27.41%
6.91
0.45%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 28
EPS
Q2Q % growth
-0.89
-8.49%
-0.97
-40.29%
-0.98
29.15%
-0.62
2.89%
-4.39
-393.12%
-0.89
Revenue
Q2Q % growth
5.327M
239.95%
6.574M
24.93%
10.894M
194.35%
7.293M
30.98%
22.338M
319.34%
N/A
EBITDA
Q2Q % growth
-45.118M
-14.79%
-48.069M
-41.34%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-51.081M
-16.54%
-59.117M
-40.20%
-61.506M
-24.42%
-20.502M
58.68%
N/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

QURE Yearly Revenue VS EstimatesQURE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
QURE Yearly EPS VS EstimatesQURE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
29.90%
EPS Next 5 Year
29.94%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
109.13%
Revenue Next 5 Year
122.75%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
9.41%
EBIT Next 5 Year
37.04%

UNIQURE NV / QURE Forecast FAQ

Can you provide the average price target for UNIQURE NV stock?

22 analysts have analysed QURE and the average price target is 51.51 USD. This implies a price increase of 216.59% is expected in the next year compared to the current price of 16.27.

What are the consensus estimates for QURE stock next earnings?

The consensus EPS estimate for the next earnings of UNIQURE NV (QURE) is -0.89 USD and the consensus revenue estimate is 5.33M USD.

What is the expected long term growth rate for QURE stock?

The expected long term growth rate for UNIQURE NV (QURE) is 109.13%.